A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of VX-770 to Evaluate Safety, Pharmacokinetics and Biomarkers of CFTR Activity in Cystic Fibrosis (CF)
|Effective start/end date||4/1/07 → 5/31/09|
- Pharmaceutical Product Development, Inc.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.